Author

Silvio Danese 1

1 Humanitas Clinical and Research Center, IRCCS,Rozzano,Italy

COST-UTILITY OF BIOSIMILAR INFLIXIMAB (INFLECTRA©) FOR THE TREATMENT OF LUMINAL CROHN?S DISEASE IN NINE EUROPEAN COUNTRIES

Fanni Rencz, Valentin Brodszky, Petra Baji, Marta Pentek, Laszlo Gulacsi, Petra Anna Golovics, Zsuzsanna Vegh, Krisztina Barbara Gecse, Silvio Danese, Peter Irving, Peter L Lakatos

DE-ESCALATING THERAPY IN PATIENTS WITH CROHN'S DISEASE RECEIVING ADALIMUMAB: A SUBGROUP ANALYSIS OF THE CALM STUDY

Peter Bossuyt, Geert R. D'Haens, Remo Panaccione, William Sandborn, Walter Reinisch, Simon Travis, Stefan Schreiber, Alessandro Armuzzi, Silvio Danese, Sofie Berg, Joel Petersson, Jen-Fue Maa, Ezequiel Neimark, Jean-Frederic Colombel

European Consensus on the Diagnosis and Management of Iron Deficiency and Anaemia in Inflammatory Bowel Diseases

Axel Dignass, Christoph Gasché, Dominik Bettenworth, Gunnar Birgegard, Silvio Danese, Javier Gisbert, Fernando Gomollon Garcia, Tariq Iqbal, Konstantinos H. Katsanos, Ioannis Koutroubakis, Fernando Jose Magro Dias, Guillaume Savoye, Jürgen Stein, Stephan Vavricka

Assessment of Budesonide MMX® effectiveness for active, mild-to-moderate ulcerative colitis in the Polish sub-group of the prospective multi-center observational study CORE Practice

Grażyna Rydzewska, Kristine Paridaens, Silvio Danese, Maciej Jesionowski

CORRELATION OF BIOMARKERS OF INFLAMMATION WITH CLINICAL AND ENDOSCOPIC ENDPOINTS IN PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE: DATA FROM CELEST

Jean-Frederic Colombel, Laurent Peyrin-Biroulet, Silvio Danese, Simon Travis, Gerald Dryden, Robert Hardi, Michael S Epstein, Wen Zhou, Fabio Cataldi, Bidan Huang, Ana Paula Lacerda, Julian Panés

COMPARATIVE ACCURACY OF BOWEL ULTRASOUND VERSUS MAGNETIC RESONANCE ENTEROGRAPHY AND COLONOSCOPY IN ASSESSING DISEASE ACTIVITY AND COMPLICATIONS AND INFLUENCING THE DECISION-MAKING PROCESS IN CROHN’S DISEASE

Mariangela Allocca, Gionata Fiorino, Cristiana Bonifacio, Federica Furfaro, Daniela Gilardi, Simona Radice, Laurent Peyrin-Biroulet, Silvio Danese

EFFICACY AND SAFETY OF IBD98E, A SODIUM HYALURONATE TOPICAL PREPARATION, IN THE INDUCTION OF CLINICAL AND ENDOSCOPIC REMISSION IN PATIENTS WITH DISTAL ULCERATIVE COLITIS: AN OPEN LABEL PILOT STUDY

Gionata Fiorino, Daniela Gilardi, Patrizia Naccarato, Orsola R Sociale, Silvio Danese

Efficacy and Safety of Ustekinumab for Ulcerative Colitis Through 2 Years: UNIFI Long-term Extension

Bruce E. Sands, William Sandborn, Remo Panaccione, Christopher D. O'Brien, Hongyan Zhang, Jewel Johanns, Yiying Zhou, Ilia Tikhonov, Laurent Peyrin-Biroulet, Gert Van Assche, Silvio Danese, Stephan Targan, Maria T. Abreu, Tadakazu Hisamatsu, Ellen Scherl, Rupert W Leong, David Rowbotham, Ramesh P. Arasaradnam, Colleen W.

Efficacy of Ustekinumab Subcutaneous Maintenance Treatment by Induction-Dose Subgroup in the UNIFI Study of Patients with Ulcerative Colitis

Silvio Danese, Bruce E. Sands, William Sandborn, Colleen W. Marano, Christopher D. O'Brien, Hongyan Zhang, Jewel Johanns, Laurent Peyrin-Biroulet, Ellen Scherl, Tadakazu Hisamatsu, Remo Panaccione

High versus standard adalimumab induction dosing regimens in patients with moderately to severely active ulcerative colitis: results from the SERENE-UC induction study

Julian Panés, Jean-Frederic Colombel, Geert R. D'Haens, Stefan Schreiber, Remo Panaccione, Laurent Peyrin-Biroulet, Edward Loftus, Jr, Silvio Danese, Edouard Louis, Alessandro Armuzzi, Marc Ferrante, Harald Vogelsang, Jessica Lefebvre, Thao Doan, Nisha V. Kwatra, Nael M. Mostafa, Wangang Xie, Bidan Huang, Joel Petersson;;

Item 1 - 10 / 66
1
2 3 4 5 6 7
We use cookies in order to provide you with a better browsing experience. This includes third-party cookies for traffic analyzation purposes. See here for more information.
OK